MedTrace Logo

Therapeutic Touch in Cancer Patients Receiving Palliative Care

NCT07524179 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2026-04-13

No results posted yet for this study

Summary

This study aims to examine the effect of therapeutic touch applied to advanced cancer patients receiving palliative care on sleep quality and fatigue severity. This is a randomized controlled experimental study using a pretest-posttest design. The study includes advanced-stage cancer patients receiving support in a palliative care unit. Research data will be collected from patients between March and August 2024 using face-to-face interviews. The intervention group will receive therapeutic touch for 20 minutes per day for 5 consecutive days, while the control group will continue to receive routine palliative care. Data will be collected using a Personal Information Form, the Richards-Campbell Sleep Questionnaire (RCSQ), and the Fatigue Severity Scale (FSS).

Conditions

  • Cancer
  • Palliative Care
  • Therapeutic Touch
  • Sleep
  • Fatigue Syndrome, Chronic

Interventions

BEHAVIORAL

Therapeutic Touch

Therapeutic touch was applied to the head, shoulders, hands and feet for approximately 10-15 minutes per day for 5 consecutive days. The application was performed between 18:00-22:00 in the patient's room with privacy ensured. The protocol consisted of light, rhythmic touches based on the effleurage (stroking) technique.

OTHER

Routine Palliative Care

Participants continued with routine palliative care protocols. No therapeutic touch or other specific touch-based intervention was applied.

Sponsors & Collaborators

  • Erzurum Technical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2024-08-01
Completion
2024-08-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07524179 on ClinicalTrials.gov